AXOGEN INC. - COMMON STOCK

Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023

18 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences

31 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio

21 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 Second Quarter Financial Results

07 Aug 2023 16:01:10 By Nasdaq GlobeNewswire

Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference

27 Jul 2023 07:00:01 By Nasdaq GlobeNewswire

Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023

26 Jul 2023 07:00:01 By Nasdaq GlobeNewswire

Axogen to Participate at Jefferies Healthcare Conference

24 May 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen to Participate at JMP Securities Life Sciences Conference

12 May 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 First Quarter Financial Results

09 May 2023 07:00:03 By Nasdaq GlobeNewswire

Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023

18 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results

14 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel

06 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023

02 Mar 2023 16:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer

13 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

09 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits

05 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

04 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

19 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Third Quarter Financial Results

08 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences

03 Nov 2022 16:00:00 By Nasdaq GlobeNewswire